Анна Владимировна Лискер

Анна Владимировна Лискер

Auto-generated profile, based on publicly available information

Анна Владимировна Лискер

Pavlov First Saint Petersburg State Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Endocrinology: News, Opinions, Training
Verified
Journal Article
Closed access
AVA.R. Volkova
A.R. Volkova
MCM.E. Chernaya
M.E. Chernaya
ALA.V. Lisker
A.V. Lisker
KVK.A. Vlasova
K.A. Vlasova
AFAcademician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of the Russian Federation"
Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of the Russian Federation"
Analysis of the experience of using insulin therapy with the closed loop method among patients with type 1 diabetes in Russia

1 January 2025 in Endocrinology: News, Opinions, Training
Verified
Journal Article
Open access
AAA.S. Ametov
A.S. Ametov
VSV.V. Salukhov
V.V. Salukhov
MAMinistry Of Defense Of The Russian Federation Kirov Military Medical Academy
Ministry Of Defense Of The Russian Federation Kirov Military Medical Academy
EBElena Baranova
Elena Baranova
NBN.V. Bakulina
N.V. Bakulina
ALA.V. Lisker
A.V. Lisker
Резолюция Междисциплинарного совета экспертов: место ингибиторов натрий-глюкозного котранспортера 2 типа в лечении пациентов с сахарным диабетом 2

10 May 2026 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Closed access
ZSZ. V. Shvets
Z. V. Shvets
SDS. V. Dora
S. V. Dora
YKYu. Sh. Khalimov
Yu. Sh. Khalimov
ALA. V. Lisker
A. V. Lisker
AKA. B. Kolyabina
A. B. Kolyabina
Aim: to evaluate an effect of laparoscopic sleeve gastrectomy (LSG) on fertility in obese reproductive age women and to identify factors associated with subsequent pregnancy. Materials and Methods. This single-center observational retrospective comparative study included 48 women aged 25–36 years who underwent LSG. Body mass index (BMI), insulin resistance index HOMA-IR (Homeostasis Model Assessment of Insulin Resistance), anti-Müllerian hormone (AMH), and antral follicle count (AFC) were assessed before and 12 months post-surgery. Smoking history, family history of premature menopause, and prior ovarian surgery were analyzed. After 3 years post-surgery, patients planning pregnancy were stratified as follows: Group 1 – achieved pregnancy (n = 16, including 10 spontaneous and 6 through assisted reproductive technologies), Group 2 – no pregnancy (n = 14). Results. Following LSG, significant reductions were observed in BMI (from 44.2 to 31.3 kg/m2; p = 0.001) and HOMA-IR index (from 8.3 to 5.1; p = 0.001). Pregnancy occurred in 53.3 % of patients. Women who did not conceive had higher baseline BMI (47.1 kg/m2 vs. 41.5 kg/m2; p = 0.025), HOMA-IR index (10.2 vs. 5.8; p = 0.005), and more pronounced decline in ovarian reserve post-LSG: AMG level was 0.89 vs. 2.65 ng/ml (p = 0.001). Significant risk factors included familial history of premature menopause (85.7 %), ovarian surgery (42.9 %), and smoking (78.6 %). Correlation analysis revealed significant negative associations between pregnancy likelihood and baseline BMI (r = –0.42; p = 0.02) and HOMA-IR (r = –0.52; p = 0.003), whereas AFC showed positive correlation (r = 0.38; p = 0.04). Statistically significant associations were found between pregnancy and smoking (p = 0.02), prior ovarian surgery (p = 0.02), and familial history of early menopause (p = 0.04). Conclusion. LSG use was associated with improved metabolic parameters and fertility recovery in 53.3 % of patients. However, given the small sample size, these findings require validation in larger-scale cohorts. The likelihood of achieving pregnancy depends on a complex interplay between the examined factors, underscoring a need for individualized risk assessment and a personalized approach to therapy.

1 January 2025 in Therapist’s Bulletin
Verified
Journal Article
Closed access
MZM.V. Zimina
M.V. Zimina
RPRussian Federation Saint Petersburg
Russian Federation Saint Petersburg
SDS.V. Dora
S.V. Dora
YKYu.SH. Khalimov
Yu.SH. Khalimov
ALA.V. Lisker
A.V. Lisker
AMA.SH. Mamedova
A.SH. Mamedova
Aim. To investigate the association between premature ovarian insufficiency (POI) and the development of metabolic syndrome in women. Design. A single-center, cross-sectional comparative study. Materials and methods. The study included 80 women divided into three groups: Group 1 (control, n = 39) — women with regular menstrual cycles and normal levels of follicle-stimulating hormone (FSH) and estradiol; Group 2 (n = 24) — women with amenorrhea lasting 3–12 months and elevated FSH > 25 IU/L (POI); Group 3 (n = 17) — women with amenorrhea lasting > 12 months and persistently elevated FSH (premature menopause, PM). Anthropometric parameters, blood pressure, and laboratory markers of carbohydrate and lipid metabolism were analyzed. Results. Women with estrogen deficiency (Groups 2 and 3) exhibited significantly higher body mass index, waist circumference, systolic and diastolic blood pressure, and adverse changes in lipid profile, including decreased high-density lipoprotein, elevated low-density lipoprotein, and triglycerides. Additionally, a considerable proportion of PM patients showed impaired fasting glucose, indicating a high risk of insulin resistance and type 2 diabetes. The prevalence of metabolic syndrome (based on IDF criteria) was 47.6% in the POI group and 52.9% in the PM group. Conclusion. Premature ovarian insufficiency and premature menopause are associated with significant metabolic disturbances, including abdominal obesity, hypertension, dyslipidemia, and impaired glucose metabolism. These conditions represent independent risk factors for metabolic syndrome in young women. Early diagnosis and prevention of metabolic complications in this patient population are of crucial clinical importance. Large-scale multicenter studies are needed to validate these findings. Keywords: premature ovarian insufficiency, premature menopause, metabolic syndrome, abdominal obesity, hypoestrogenism.

1 January 2021 in Endocrinology: News, Opinions, Training
Verified
Journal Article
Closed access
AVA.R. Volkova
A.R. Volkova
ALA.V. Lisker
A.V. Lisker
GSG.V. Semikova
G.V. Semikova
VMV.S. Mozgunova
V.S. Mozgunova

1 January 2023 in Endocrinology: News, Opinions, Training
Verified
Journal Article
Closed access
MCM.E. Chernaya
M.E. Chernaya
AOA.D. Orlovskaya
A.D. Orlovskaya
APAlexey Polushin
Alexey Polushin
YZYu.R. Zalyalov
Yu.R. Zalyalov
ALA.V. Lisker
A.V. Lisker
AKAlexander Kulagin
Alexander Kulagin